<?xml version="1.0" encoding="UTF-8"?>
<ref id="B177">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Vuorinen</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Engeli</surname>
    <given-names>R. T.</given-names>
   </name>
   <name>
    <surname>Leugger</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Bachmann</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Akram</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Atanasov</surname>
    <given-names>A. G.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2017</year>). 
  <article-title>Potential antiosteoporotic natural product lead compounds that inhibit 17β-hydroxysteroid dehydrogenase type 2</article-title>. 
  <source>J. Nat. Prod.</source>
  <volume>80</volume> (
  <issue>4</issue>), 
  <fpage>965</fpage>–
  <lpage>974</lpage>. 
  <pub-id pub-id-type="doi">10.1021/acs.jnatprod.6b00950</pub-id>
  <pub-id pub-id-type="pmid">28319389</pub-id>
 </mixed-citation>
</ref>
